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Abstract  
AIM: Aim of this study was to examine the effectiveness of body acupuncture on body weight loss, 
routine laboratory tests and pro-inflammatory markers. 
METHODOLOGY: The study was performed on eighty obese patients. They were divided into three 
groups according to their body mass index. Subjects received acupuncture for three- six months in 
combination with a low-calorie diet. They were assessed pre and post acupuncture, by 
anthropometric measurement, routine laboratory tests and, tumor necrosis factor- alpha (TNF-α), 
interleukin- 6 (IL-6), and high sensitivity C-reactive protein (hsCRP) levels in serum. 
RESULTS: The pre-acupuncture results showed significant difference between the three grades of 
obesity and the controls regarding TNFα, IL-6 and hsCRP. We found significant reduction in 
anthropometric measurement of adiposity after acupuncture. In comparing the pre &post 
acupuncture results of TNF-α, IL-6 and hsCRP showed high significant reduction after acupuncture. 
There are highly significant decrease in kidney function (creatinine and uric acid) and lipid profile 
(cholesterol and triglycerides) and fasting blood glucose, but there was no significant difference in 
urea, SGPT, SGOT, HDL and LDL. 
CONCLUSION: Body acupuncture in combination with diet restriction was found to be effective for 
weight loss and also reduction of the inflammatory reactions. Acupuncture could be used as a 
synergistic treatment option for obesity control. 
 
 
 
 
 
Introduction 
 
Obesity is a chronic non-communicable 
disease with clinical and public health challenges [1]. 
Studies on human and animal models indicated that 
adipocytes secrete many inflammatory cytokines, and 
hence the excess of fat in obesity leads to a systemic 
chronic inflammation [2]. It is now admitted that the 
majority of inflammatory peptides is secreted by 
adipose tissue-resident macrophages [3]. 
Tumor necrosis factor-alpha (TNF-) and 
interleukin-6 (IL6) are the most important cytokines 
responsible for the chronic inflammatory process [4]. 
In adults, their serum concentrations have been 
reported to correlate positively with measures of 
adiposity and to associate with the metabolic 
syndrome, cardiovascular disease, insulin resistance, 
and diabetes [2]. 
High sensitivity C-reactive protein (hsCRP) is 
a very sensitive marker of inflammation, which is 
synthesized in the liver, and this process is regulated 
predominately by IL-6 [4]. hsCRP is positively 
correlated with abdominal fat and closely correlated 
with increased risk of cardiovascular events [5]. 
Acupuncture originated in China more than 
2,000 years ago, and is one of the oldest medical 
procedures in the world. Acupuncture involves the 
insertion of very fine, sterile needles at specific body 
points or "energy pathways." The inserted needles act 
to stimulate the release of endorphins, the body’s 
natural "feel good" hormones. This can create a 
calming, relaxing effect, which counteracts the need 
for excessive eating brought about by increased 
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stress, frustration or anxiety. In this respect, 
acupuncture can calm those so afflicted and help 
them lose weight without resorting to drugs [6]. 
Recent research has examined some of the 
mechanisms underpinning acupuncture's anti-
inflammatory effects which include mediation by 
sympathetic and parasympathetic pathways. Other 
reported anti-inflammatory effects of acupuncture 
include an antihistamine action and downregulation of 
proinflammatory cytokines such as TNF-α, IL-1β, IL-6, 
and IL-10 [7]. 
There are several studies which have 
evaluated the effect of acupuncture in the 
management of obesity [8, 9]. Acupuncture has been 
used in the treatment of several diseases including 
obesity and also immune-related diseases, such as 
allergic disorders, autoimmune diseases, and 
immunodeficiency [9]. However, most studies have 
methodological limitations, including small sample 
size and inadequately controlled study design [9].  
To our knowledge, the effect of acupuncture 
during body weight loss has not been evaluated with 
respect to inflammatory and immunological markers 
such as TNF-α, IL-6 and hsCRP in Egyptian 
population. Thus, the aim of this study was to examine 
the effectiveness of body acupuncture on body weight 
loss, routine laboratory tests and pro-inflammatory 
markers (TNF-α, IL-6 and hsCRP). 
 
 
Methods and Subjects 
 
Study design 
A randomized controlled clinical trial was 
performed on 80 obese patients entered in our project 
at National Research Centre. They were divided into 3 
groups according to their body mass index (BMI). 
Subjects received acupuncture for 6 months in 
combination with a low-calorie diet. 
In this study, overweight was defined as a 
body mass index (BMI) of 25 to < 30 and a BMI of ≥30 
were defined as obesity. They neither had received 
any other weight control measures nor had any 
medical and/or drug history within the last 3 months 
before their participation in the study. Only classical 
Chinese body acupuncture and auricular acupuncture 
were allowed to be used. Those whom had diabetes, 
hypertension, heart disease, endocrine abnormalities, 
or pregnancy were excluded. 
Participants were informed about the study 
both verbally and by written information sheets. 
Volunteers were given time to discuss the study and 
were encouraged to ask questions.  
Controls were required to be placebo, no 
treatment, pharmacological or non pharmacological 
interventions (e.g. diet and exercise). 
Anthropometric Measurements 
For all patients, body weight (BW), BMI, and 
body fat mass were measured by body composition 
analyzer BC-418 (TANITA, Japan) according to a 
standard protocol. Height and body weight were 
measured with the subjects dressed in light clothing 
after an overnight fasting. The body weight of each 
subject was measured with a standard scale to an 
accuracy of ± 0.1 kg, and height was measured to an 
accuracy of ± 0.1 cm.  
 
Acupuncture Treatment in Cases 
Body points are: Hegu (LI4), Quchi (LI11), 
Liangmen (ST21), Tianshu (ST25), Zusanli (ST36), 
Fenglong (ST40), Neiting(ST44), Sanyinjiao(SP6), 
Daheng (SP15), Neiguan (PC6), Taichong (LR3), 
Guanyuan (CV4) and Zhongwan (CV12). 
Acupuncture sessions was done twice 
weekly, each session was 30 minutes. 
Auricular acupuncture: ear points are: 
Shenmen, Mouth, Stomach, Sanjiao, Liver, 
Spleen,Endocrine and Hunger points [10]. 
They are weekly applied to each ear 
alternatively. 
 
Collection of Blood Samples 
About 5 ml of venous blood samples were 
taken from each patient for analysis after a 12-hour 
fasting, 2 times during the study (at the beginning and 
6 months later). Blood samples were collected into 
vacutainer tubes and centrifuged at 4000 rpm for 10 
min. Hemolyzed samples were excluded from 
analysis. After separation, routine analysis was done 
and aliquots of serum were frozen at − 80°C for TNF-
α, IL-6 and hsCRP analysis. 
 
Routine Biochemical Analysis and Serum 
TNF-α, IL-6 and hsCRP analysis 
Fasting blood glucose (FBG) was determined 
immediately on Olympus auto analyzer using 
hexokinase method. Serum GOT, GPT, urea, 
creatinine, uric acid (UA), cholesterol, triglycerides 
(TG) were determined using colorimetric methods on 
Olympus AU 400 supplied from Olympus Life and 
Material Science (Europe GmbH, Wendenstraße, 
Hamburg, Germany). 
TNF-α was determined by ELISA [11] kit 
supplied from Anogen (2355 Derry Road East, Unit 
23, Mississauga, Ontario, Canada). Il-6 was 
determined by ELISA [12] kit supplied from AviBion 
(Ani Biotech, tiilitie, Finland). Quantitative 
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determination of hsCRP in serum is done by a micro 
plate immuoezymometric assay [13] supplied from 
Monobind Inc. (100 North Pointe drive, Lake Forest, 
USA). 
 
Statistical analysis 
Data was statistically described in terms of 
mean ± standard deviation (± SD), frequencies 
(number of cases) and percentages when appropriate. 
Comparison of numerical variables between the study 
groups was done using Mann Whitney U test for 
independent samples when comparing 2 groups and 
Kruskal Wallis test with Mann Whitney U test as post-
hoc multiple 2-group comparisons when comparing 
more than 2 groups. For comparing pre and post 
acupunctures, Wilcoxon signed-rank test was used for 
continuous variables and McNemar test for two 
related dichotomous variables for detecting changes 
in responses due to intervention. P value less than 
0.05 was considered statistically significant. All 
statistical calculations were done using computer 
programs SPSS (Statistical Package for the Social 
Science; SPSS Inc., Chicago, IL, USA) version 15 for 
Microsoft Windows. 
 
 
Results 
 
Table 1 shows that females represented 
93.5% of the total 80 persons. Regarding BMI, obese 
patients were divided into three groups: obese I (BMI 
ranged 30 to 35) represented 27.5%, obese 2 (BMI 
ranged 35 to 40) represented 42.5% and obese 3 
whose BMI was > 40 which and represented 30%. 
Steady pattern of weight gain was reported by about 
40% of the studied population.  
 
Table 1: General characteristics of the studied group (number 
(%). 
Characters Total no= 80 
Sex: 
Male 
Female 
 
6 (6.5) 
74 (93.5) 
BMI: (Kg/m
2
) 
30-35 (group1) 
35-40 (group2) 
>40 (group3) 
 
22 (27.5) 
34 (42,5) 
24 (30.0) 
Wt. gain pattern: (%) 
Steady 
Sudden increase 
Wt. gain after loss 
 
32 (40,0) 
5 (6.3) 
43 (53.7) 
 
There was a significant difference between 
the three groups of obesity and the controls regarding 
inflammatory mediators. Routine laboratory results 
showed that there were no significant differences 
between three groups of obesity and controls (Table 
2).   
 
Table 2: Comparison between obesity and control groups 
regarding routine laboratory tests and levels of inflammatory 
mediators (TNF-α, IL-6, hsCRP) pre acupuncture (mean ± SD).  
Tests 
Obese I 
n=22 
 
Obese 2 
n=34 
 
Obese 3 
n=24 
 
Controls 
n=23 
 
P value 
Creatinine (mg/dL) 0.7 ± 0.3 0.6 ± 0.4 0.6 ±0 .4 0.9 ±0 .3 0.486 
Urea (mg/dL) 33.2 ± 13.1 27.8 ± 13.2 24.5 ± 15.5 35.4 ± 15.6 0.407 
SGOT (U/L) 23.6 ± 13.0 22.6 ± 13.4 15.8 ± 12.6 23.7 ± 9.7 0.039 
SGPT (U/L) 21.6 ± 11.3 24.7 ± 17.0 15.5 ± 14.7 11.3 ± 6.2 0.072 
Fasting blood glucose (mg/dL) 100.9 ± 12.1 97.6 ± 34.7 81.0 ± 44.1 98.0 ± 20.7 0.226 
Triglyceride (mg/dL) 140.5 ± 51.5 125.4 ± 74.6 122.2 ± 87.0 135.6 ± 30.9 0.572 
Cholesterol (mg/dL) 210.7 ± 50.4 190.8 ± 71.3 176.2 ± 96.6 154.4 ± 1.7 0.885 
Uric Acid (mg/dL) 4.9 ± 1.3 5.8 ± 1.5 5.3 ± 1.2 4.4 ± 1.7 0.152 
HDL (mg/dL) 45.3 ± 13.5 44.9 ± 11.5 40.1 ± 14.4 50.4±6.9 0.654 
LDL (mg/dL) 116.7 ±58.1 118.8 ± 42.7 137.4 ± 34.4 68.6±28.2 0. 590 
TNF-α (pg/ml) 16.7 ± 4.7 16.6 ± 4.3 17.5 ± 5.9 11.2 ± 2.2 0.045 
IL6 (pg/ml) 16.8± 8.9 15.2 ± 7.1 15.6 ± 8.2 3.8 ± 2.1 0.000 
hsCRP (g/ml) 20.5± 10.9 18.9 ± 11.9 22.5 ± 11.9 5.8  ±  3.9 0.024 
 
Table 3 shows post-acupuncture results. 
there was no significant difference between three 
groups of obesity  as regards routine lab analysis, 
except for HDL, FBG and SGPT that showed 
significant difference (P<0.05).  
Table 3: Comparison between obesity groups post 
acupuncture as regards routine lab analysis and inflammatory 
mediators (TNF-α, IL-6, hsCRP) (mean ± SD). 
Tests 
Obese I 
n=22 
 
Obese 2 
n=34 
 
Obese 3 
n=24 
 
P value 
Creatinine (mg/dl) 0.9 ± 0.2 0.8 ± 0.4 0.6 ± 0 .5 0.273 
Urea (mg/dl) 29.8 ± 14.6 31.1 ± 17.7 23.9 ± 19.6 0.355 
SGOT (U/L) 20.9 ± 11.3 19.7 ± 11.7 14.1 ± 10.7 0.398 
SGPT (U/L) 18.9 ± 10.0 19.9 ± 14.5 11.1 ± 10.2 0.032 
Fasting blood glucose 
(mg/dL) 
93.0 ± 24.3 81.5 ± 33.6 58.5 ± 39.6 0.029 
TG (mg/dL) 117.9 ± 43.8 100.2 ± 62.7 90.9 ± 78.5 0.456 
CHOL (mg/dL) 195.0 ± 33.8 165.7 ± 69.6 131.8 ± 89.6 0.208 
UA (mg/dL) 4.0 ± 1.1 4.3 ± 2.0 3.2 ± 2.3 0.173 
HDL (mg/dL) 72.5 ± 57.1 54.4 ± 33.1 31.4 ± 25.2 0.010 
LDL (mg/dL) 110.1 ± 35.0 88.6 ± 59.6 62.9 ± 63.7 0.310 
TNF -α (pg/ml) 12.5 ± 2.8 12.6 ± 3.0 13.2 ± 3.8 0.934 
IL6 (pg/ml) 14.7 ± 9.3 10.9 ± 7.8 9.0 ± 9.6 0.111 
hsCRP (g/ml) 15.4 ± 7.8 14.3 ± 8.3 18.2 ± 7.4 0.252 
 
 
Table 4 shows mean level of routine 
laboratory analysis and inflammatory mediators pre 
and post acupuncture among obese. There is highly 
significant difference P<0.01 in kidney function 
(creatinine & U.A) and lipid profile (cholesterol &TG) 
and FBG, but no significant difference was found in 
Urea, SGPT, SGOT, HDL and LDL (P>0.05). 
Table 4: Comparison between pre and post-acupuncture as 
regards anthropometric measurements, biochemical 
characteristics of participants (mean ± SD). 
Variable 
Pre acupuncture    Post acupuncture 
P value 
  
Weight (kg) 96.9 ±15.1 91.6 ± 14.6 0.001 
BMI (kg/m
2
) 38.6 ± 5.3 36.6 ± 5.0 0.001 
Body fat (%) 44.6 ± 52 42.2 ± 5.4 0.001 
Fat mass 44.1 ± 11.2 39.6 ± 10.5 0.001 
Visceral fat rating 11.8 ± 3.7 10.5 ± 3.7 0.001 
Basal metabolic rate 6992.1 ± 926.7 6829.2 ± 836.4 0.001 
Creatinin (mg/dL) 0.6 ± 0.4 0.9 ± 1.0 0.001 
Urea (mg/dL) 26.6 ± 15.1 29.0 ± 17.5 0.255 
GOT (U/L) 19.8 ± 13.6 19.1 ± 11.5 0.451 
GPT (U/L) 19.9 ± 14.6 17.9 ± 13.1 0.723 
Fasting blood glucose (mg/dL) 91.8 ± 39.3 79.0 ± 35.2 0.001 
HDL (mg/dL) 33.8 ± 20.7 37.7 ± 21.4 0.058 
LDL (mg/dL) 99.7 ± 64.4 87.3 ± 56.9 0.165 
TG (mg/dL) 133.3 ± 80.3 103.9 ± 62.4 0.001 
Cholesterol (mg/dL) 186.8 ± 80.5 166.1 ± 70.4 0.001 
UA (mg/dL) 4.9 ± 2.4 4.0 ± 2.0 0.001 
TNF-α (pg/ml) 16.9 ± 4.7 12.4 ± 3.1 0.001 
IL6 (pg/ml) 14.2 ± 8.8 10.4 ± 8.6 0.001 
hsCRP (g/ml) 21.3 ± 9.9 14.9 ± 7.7 0.001 
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TNF-α, IL6 and hsCRP showed high 
significant improvement after acupuncture by using 
non-parametricm (P<0.001).  
 
 
Discussion 
 
There are several studies which have 
evaluated the effect of acupuncture in the 
management of obesity [9, 14, 15]. Hsu et al., 
mentioned that waist circumference (WC) is related to 
the subcutaneous fat tissue of the abdomen, and 
higher effects of body acupuncture in impolitic activity 
and enhancing lipid metabolisms could be attributed 
to the direct effects of body acupuncture in 
redistribution, lyses of fat tissue and reducing waist 
circumferences [14]. In current study, different 
anthropometric measurements in cases showed 
highly significantly reduction after the acupuncture. A 
study was done by Hong also observed that 
acupuncture has the function of selectively reducing 
excrescent fat in certain parts of the body with extra 
fat accumulation without further advance after 
reaching the normal body weight [16].  However, there 
are some studies that have reported no significant 
effect of acupuncture in the treatment of obesity, but it 
should be noted that these studies were performed by 
auricular acupuncture therapy only [17, 18]. 
It is believed that acupuncture alters levels of 
central nervous system by stimulating peripheral 
nerves at acupoints. Signals are then carried by 
stimulated nerve resulting in changes in satiety and 
mood [6]. Acupuncture appears to be able to improve 
mood by increasing the release of neurotransmitters 
[19] and suppress appetite by the serotonin and 
endorphin-induced decreases in stress and 
depression [20, 21], whereas this effect was not seen 
by exercise and diet. In addition, it has been shown 
that application of electroacupuncture at Zusanli (ST-
36) and Neiting (ST-44) of the rat caused the increase 
in the electrical activity of ventral-medical 
hypothalamus in the obese rat, leading to activation of 
the satiety center (22). 
White adipose tissue (WAT) is a source of 
some proinflammatory cytokines such as TNF-α and 
IL-6, which may show both local and systemic effects 
[23, 24]. Xu et al., also reported that the increased 
expression of inflammation-specific genes by 
macrophages in the adipose tissue of obese mice 
[25]. 
Many studies showed correlation of TNF- α 
expression with increased body mass, WC [2, 4, 5]. 
Previous study on human subjects reported on the 
elevated levels of TNF-α in gingival crevicular fluid 
(GCF) of obese individuals. The authors reported on a 
0.74αpg increase in GCF TNF-α with an increase of 
one BMI unit [26]. Moreover, Hotamisligil et al., have 
shown increased expression of the TNFR2 (TNF 
receptor 2) receptor in adipose tissue in patients with 
excessive body weight. They have also demonstrated 
that the level of the TNFR2 receptor in serum is six 
times higher in obese people than among their control 
group [27]. Similarly to TNF-α, serum IL-6 expression 
correlate with increased body mass, waist 
circumference, and free fatty acid levels [3, 28] with 
reduction in circulating IL-6 following weight loss [29].  
IL-6 has been implicated as a marker for visceral 
adiposity because visceral adipose tissue releases 
more IL-6 than subcutaneous adipose tissue [30]. 
IL-6 can directly affect lipid metabolism and 
activate pathways to promote increased energy 
turnover. IL-6 stimulates lipolysis in humans, 
increases free fatty acid (FFA) concentrations and 
whole body fat oxidation adipokines [31]. Notably, IL-6 
can decrease the expression and secretion of 
adiponectin in human adipocytes, as well as other 
markers of adipocyte differentiation [32]. These 
findings are in agreement with current study that 
showed that, in pre acupuncture treatment, there is a 
significant difference between three grades of obesity 
and controls regarding TNF-α, IL6. However, in 
interesting study by Stępie et al., they reported that 
BMI did not correlate with IL-6 and TNF-α in any 
investigated subgroups [4]. These findings are in 
agreement with results obtained by Agraval et al., who 
also did not observe any significant correlation 
between IL-6 and TNF-α with BMI in a North Indian 
healthy general population as well in both sexes [33]. 
In contrast, Stępie et al., observed a significant 
inverse correlation between waist to hip ratio (WHR) 
and TNF-α in the obese male group [4]. Based on the 
data obtained from this study it is difficult to explain 
this surprising relationship. 
HsCRP is a feature of systemic inflammation 
and is positively associated with measures of 
adiposity such as BMI as demonstrated by large two 
cross-sectional studies [34, 35]. The study by Visser 
et al., included 8,678 women and demonstrated that 
obese subjects had CRP 6.21 times higher than those 
of normal weight [34]. Numerus studies found 
significant correlation between high level of hsCRP 
and measures of adiposity [3, 36, 37] and other 
studies reported reduction in hsCRP levels following 
weight loss [38, 39].  
The effects of the immune system-related 
acupoints on inflammatory cytokines, such as TNF-α, 
IL-6 and hsCRP have not been researched sufficiently 
to date. Although several trials have investigated the 
influence of some acupoints on the various cytokine 
levels, there have been no adequately controlled 
studies comparing the effects of acupoints on the 
immune system [40]. In this study, we used four of the 
most common acupoints (Ren12, Li-11, St-36, and 
Sp-6) that used conventionally in infections and 
inflammatory diseases. We reported significant 
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reduction of TNF-α and IL-6 after acupuncture. Yim 
and colleagues reported a decrease in increased 
serum TNF-α, IL-6, and IFN-γ levels as a result of 3 
weekly sessions of electroacupuncture treatment, a 
total of 5–9 weeks on the St-36 point in collagen-
induce arthritic mice. In this study, it was shown that 
acupuncture could provide a reduction in serum TNF-
α level, which was already high in inflammatory 
arthritis [41]. Likewise, Tian et al., also found that 
serum TNF-α level increased in rats with ulcerative 
colitis compared to normal rats. After that, they 
performed electroacupuncture on the St-36 point once 
a day for 10 days on these rats [42]. As a result, they 
reported that there was a decrease in TNF-α level 
compared to the control rats. On the other hand, Jong 
and his team were unable to find any changes in IL-4, 
IL-6, IL-10, soluble interleukin-2 receptor, and IFN-γ 
levels in 9 healthy individuals in whom they had 
performed electroacupuncture on the Li-11 point [43]. 
Karatay et al., mentioned that TNF-α levels that were 
already expected to be within normal levels in healthy 
individuals were not affected by the acupuncture 
treatment in all acupuncture groups in which St-36 
and Li-11 were also included [44]. Immediately after a 
single acupuncture treatment, Petti et al., also 
reported a significant decrease in IL-10, no significant 
change in IL-6, and an unexpected significant 
decrease in IL-2. Since the effects of a single 
acupuncture treatment are not likely to accurately 
predict the effects of a substantial course of 
acupuncture, it is difficult to interpret the results of this 
study [45]. 
This study showed significant reduction in hs-
CRP level after weight reduction by acupuncture 
treatment. Many studies have found the same result 
as ours about the reduction in hsCRP levels following 
weight loss [4, 46]. Other studies by Hamid et al., 
found that changes in hs-CRP levels were not 
different between cases and control, implying this 
notion that hs-CRP changed independent of the 
effects of acupuncture [9].  In patients with 
rheumatologic problems that showed increase hsCRP 
serum level, some studies reported the inability of 
acupuncture to reduce hs-CRP levels [47, 48] and 
some other not [49]. 
At the end, some potential reasons for these 
discrepancies among different studies could be due to 
the differences in age, race, pubertal stage, obesity 
degree, and fat distribution. 
In conclusion, obesity-associated risks factors 
reduction can be achieved by other modalities but due 
to lack of adverse events and continued effects after 
the therapy, acupuncture could be used as a proffered 
or synergic treatment option for obesity control.  
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